In non-COVID-19 prospective controlled study conducted on 142 septic, septic shock and healthy individuals revealed that both the initial and follow-up PTX3 levels were consistently significantly higher in patients who died than in those who recovered (initial P = 0.004; follow-up P < 0.001). This evidence concerns the gene PTX3 and COVID-19.